A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously ...

As multi-cancer early detection (MCED) testing gains momentum, experts are honing their focus on what comes next for patients with a positive MCED test result. Understanding the diagnostic pathways ...

New research reveals that a cancer-related signaling pathway plays a key role in maintaining blood vessel integrity in the ...

Immune checkpoint blockade (ICB) therapies have revolutionized cancer treatment, yet many tumors remain resistant. Now, ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

Researchers have uncovered a surprising connection between a cancer-related signaling pathway and the blood-brain and blood-retina barriers.

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Announcing a new article publication for BIO Integration journal. Imbalances in the intestinal microbiome are closely ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.

A study published in PNAS and led by Prof. LIANG Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...